• Enforcement priorities and policies regarding communications by pharmaceutical and medical device manufacturers about their medical products.

Duration: September 24, 2014 to December 20, 2022

General Issues: Health Issues, Medical/Disease Research/Clinical Labs

Spending: about $1,010,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2014: Justice - Dept of (DOJ), House of Representatives, U.S. Senate, Food & Drug Administration (FDA)

Affiliated organizations: Allergan, Inc; Amgen Inc.; Bayer Healthcare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Genentech, Inc.; GlaxoSmithKline LLC; Johnson & Johnson Services, Inc.; Novo Nordisk, Inc.; Pfizer, Inc.; Sanofi US Services Inc.; Novartis Pharmaceutical Corporation

Related Foreign Entities: Bayer AG (Leverkusen, GER); contribution to lobbying: $0; ownership 0%; Boehringer Ingelheim GmbH (Ingelheim, GER); contribution to lobbying: $0; ownership 0%; GlaxoSmithKline, PLC (Middlesex, GBR); contribution to lobbying: $0; ownership 0%; Novo Nordisk Fonden (Hellerup, DEN); contribution to lobbying: $0; ownership 0%; Novo A/S (Hellerup, DEN); contribution to lobbying: $0; ownership 0%; Novo Nordisk A/S (Hellerup, DEN); contribution to lobbying: $0; ownership 0%; Sanofi-Aventis SA (Paris, FRA); contribution to lobbying: $0; ownership 0%; F. Hoffmann-La Roche Ltd. (Basel, SUI); contribution to lobbying: $0; ownership 0%